State of Tennessee, Department of Treasury’s Sarepta Therapeutics SRPT Stock Holding History

State of Tennessee, Department of Treasury’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$690K	Sell	38,387 -953	-2%	-$18K	﹤0.01%	1382
2026 Q1	$856K	Sell	39,340 -565	-1%	-$10.9K	﹤0.01%	1264
2025 Q4	$812K	Sell	39,905 -2,565	-6%	-$54.1K	﹤0.01%	1264
2025 Q3	$818K	Buy	42,470 +2,726	+7%	+$48.6K	﹤0.01%	1265
2025 Q2	$680K	Hold	39,744	–	–	﹤0.01%	1301
2025 Q1	$2.54M	Sell	39,744 -1,086	-3%	-$114K	0.01%	776
2024 Q4	$4.96M	Sell	40,830 -1,152	-3%	-$141K	0.02%	544
2024 Q3	$5.24M	Sell	41,982 -981	-2%	-$136K	0.02%	540
2024 Q2	$6.79M	Buy	+42,963	New	+$5.52M	0.02%	462
2019 Q2	–	Sell	-20,000	Closed	-$2.38M	–	1619
2019 Q1	$2.38M	Buy	+20,000	New	+$2.57M	0.01%	754

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State of Tennessee, Department of Treasury's SRPT Position: Q2 2026 in Review

State of Tennessee, Department of Treasury reduced its Sarepta Therapeutics (SRPT) stake by 2.4% in Q2 2026, selling an estimated $18K and leaving 38,387 shares worth $690K. The position accounts for ﹤0.01% of the portfolio, ranked #1382.

State of Tennessee, Department of Treasury first reported a position in SRPT in Q1 2019 and has held it in 10 quarters since. The position peaked at $6.79M in Q2 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

State of Tennessee, Department of Treasury held 38,387 shares of Sarepta Therapeutics worth $690K as of Q2 2026.
State of Tennessee, Department of Treasury sold 953 Sarepta Therapeutics shares in Q2 2026, an estimated $18K.
Sarepta Therapeutics made up ﹤0.01% of State of Tennessee, Department of Treasury's portfolio in Q2 2026, its #1382 holding.
State of Tennessee, Department of Treasury first reported a position in Sarepta Therapeutics in Q1 2019 and has held it in 10 quarters since.
State of Tennessee, Department of Treasury's Sarepta Therapeutics position peaked at $6.79M in Q2 2024.
323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on State of Tennessee, Department of Treasury's 13F filing for Q2 2026, filed 14 Aug 2026.